174 related articles for article (PubMed ID: 37537527)
1. Proton beam therapy for hepatocellular carcinoma with bile duct invasion.
Iizumi T; Okumura T; Hasegawa N; Ishige K; Fukuda K; Seo E; Makishima H; Niitsu H; Takahashi M; Sekino Y; Takahashi H; Takizawa D; Oshiro Y; Baba K; Murakami M; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
BMC Gastroenterol; 2023 Aug; 23(1):267. PubMed ID: 37537527
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
[TBL] [Abstract][Full Text] [Related]
3. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
Kim TH; Koh YH; Kim BH; Kim MJ; Lee JH; Park B; Park JW
J Hepatol; 2021 Mar; 74(3):603-612. PubMed ID: 33031846
[TBL] [Abstract][Full Text] [Related]
4. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.
Chadha AS; Gunther JR; Hsieh CE; Aliru M; Mahadevan LS; Venkatesulu BP; Crane CH; Das P; Herman JM; Koay EJ; Taniguchi C; Holliday EB; Minsky BD; Suh Y; Park P; Sawakuchi G; Beddar S; Odisio BC; Gupta S; Loyer E; Kaur H; Raghav K; Javle MM; Kaseb AO; Krishnan S
Radiother Oncol; 2019 Apr; 133():54-61. PubMed ID: 30935582
[TBL] [Abstract][Full Text] [Related]
5. Proton Beam Therapy for Hepatocellular Carcinoma: Multicenter Prospective Registry Study in Japan.
Mizumoto M; Ogino H; Okumura T; Terashima K; Murakami M; Ogino T; Tamamura H; Akimoto T; Waki T; Katoh N; Araya M; Onoe T; Takagi M; Iwata H; Numajiri H; Okimoto T; Uchinami Y; Maruo K; Shibuya K; Sakurai H
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):725-733. PubMed ID: 37778422
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.
Iizumi T; Okumura T; Sekino Y; Takahashi H; Tsai YL; Takizawa D; Ishida T; Hiroshima Y; Nakamura M; Shimizu S; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
J Radiat Res; 2021 Jul; 62(4):682-687. PubMed ID: 34036362
[TBL] [Abstract][Full Text] [Related]
7. Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.
Sekino Y; Okumura T; Fukumitsu N; Iizumi T; Numajiri H; Mizumoto M; Nakai K; Nonaka T; Ishikawa H; Sakurai H
J Cancer Res Clin Oncol; 2020 Mar; 146(3):711-720. PubMed ID: 31776663
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma.
Fukuda K; Okumura T; Abei M; Fukumitsu N; Ishige K; Mizumoto M; Hasegawa N; Numajiri H; Ohnishi K; Ishikawa H; Tsuboi K; Sakurai H; Hyodo I
Cancer Sci; 2017 Mar; 108(3):497-503. PubMed ID: 28012214
[TBL] [Abstract][Full Text] [Related]
9. Combination of Lenvatinib and Proton Beam Therapy in the Management of Patients With Advanced Hepatocellular Carcinoma.
Cheng JY; Huang BS; Chen YY; Wang CC; Chen YH
Anticancer Res; 2023 Mar; 43(3):1361-1371. PubMed ID: 36854503
[TBL] [Abstract][Full Text] [Related]
10. Proton Beam Therapy in Managing Unresectable Hepatocellular Carcinoma with Bile Duct Invasion.
Lee CH; Chen AH; Hung SP; Hsieh CE; Tseng JH; Chen PJ; Cheng JY; Chang JT; Chan KM; Lin SM; Lin CC; Chen WT; Chen WY; Huang BS
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406392
[TBL] [Abstract][Full Text] [Related]
11. Impact of Proton Beam Irradiation of an Anatomic Subsegment of the Liver for Hepatocellular Carcinoma.
Hojo H; Raturi V; Nakamura N; Arahira S; Akita T; Mitsunaga S; Nakamura M; Motegi A; Kageyama SI; Zenda S; Okumura M; Ikeda M; Akimoto T
Pract Radiat Oncol; 2020; 10(4):e264-e271. PubMed ID: 31585204
[TBL] [Abstract][Full Text] [Related]
12. Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-Small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
Ohnishi K; Nakamura N; Harada H; Tokumaru S; Wada H; Arimura T; Iwata H; Sato Y; Sekino Y; Tamamura H; Mizoe JE; Ogino T; Ishikawa H; Kikuchi Y; Okimoto T; Murayama S; Akimoto T; Sakurai H
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):82-89. PubMed ID: 31580927
[TBL] [Abstract][Full Text] [Related]
13. Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis.
Kim DY; Park JW; Kim TH; Kim BH; Moon SH; Kim SS; Woo SM; Koh YH; Lee WJ; Kim CM
Radiother Oncol; 2017 Jan; 122(1):122-129. PubMed ID: 28034460
[TBL] [Abstract][Full Text] [Related]
14. A Phase 2 Study of Image-Guided Proton Therapy for Operable or Ablation-Treatable Primary Hepatocellular Carcinoma.
Iwata H; Ogino H; Hattori Y; Nakajima K; Nomura K; Hashimoto S; Hayashi K; Toshito T; Sasaki S; Mizoe JE; Shibamoto Y
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):117-126. PubMed ID: 33798564
[TBL] [Abstract][Full Text] [Related]
15. Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies.
Yeung R; Bowen SR; Chapman TR; MacLennan GT; Apisarnthanarax S
Pract Radiat Oncol; 2018; 8(4):287-293. PubMed ID: 29452863
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes of Patients With Unresectable Cholangiocarcinoma Treated With Proton Beam Therapy.
Hung SP; Huang BS; Hsieh CE; Lee CH; Tsang NM; Chang JT; Chen JS; Chou WC; Tseng JH; Hong JH
Am J Clin Oncol; 2020 Mar; 43(3):180-186. PubMed ID: 31764017
[TBL] [Abstract][Full Text] [Related]
17. Proton beam therapy for large hepatocellular carcinoma.
Sugahara S; Oshiro Y; Nakayama H; Fukuda K; Mizumoto M; Abei M; Shoda J; Matsuzaki Y; Thono E; Tokita M; Tsuboi K; Tokuuye K
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):460-6. PubMed ID: 19427743
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion.
Tanaka T; Kuzuya T; Ishigami M; Ito T; Ishizu Y; Honda T; Ishikawa T; Fujishiro M
Oncology; 2020; 98(9):621-629. PubMed ID: 32434180
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes and toxicities of 100 patients treated with proton therapy for chordoma on the proton collaborative group prospective registry.
Chhabra AM; Rice SR; Holtzman A; Choi JI; Hasan S; Press RH; Chang J; Halasz L; Tsai HK; Wang CJ; Kabolizadeh P; Gondi V; Hartsell WF; Vora SA; Vargas CE; Simone CB
Radiother Oncol; 2023 Jun; 183():109551. PubMed ID: 36813169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
